NCT05332509 is a NA clinical trial of C-BRACE in Lower Limb, sponsored by Otto Bock France SNC.

Who is sponsoring NCT05332509?

NCT05332509 is sponsored by Otto Bock France SNC.

What drugs are being tested in NCT05332509?

Interventions in NCT05332509: C-BRACE, SCO.

What condition does NCT05332509 study?

NCT05332509 studies Lower Limb, Pareses.

Is NCT05332509 still recruiting?

NCT05332509 is currently completed. Last updated 23 June 2023.

Last reviewed 2023-06-23 · How we verify

NCT05332509

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

C-BRACE Versus SCO in Community Ambulators

Completed NA Last updated 23 June 2023

What this trial tests

NA trial testing C-BRACE in Lower Limb in 38 participants. Completed in 17 April 2023.

Timeline

19 April 2022

Primary endpoint
17 April 2023

17 April 2023

Quick facts

Lead sponsor	Otto Bock France SNC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	38
Start date	19 April 2022
Primary completion	17 April 2023
Estimated completion	17 April 2023
Sites	18 locations across France, Germany

Drugs / interventions tested

C-BRACE
SCO

Conditions studied

Lower Limb — all drugs for Lower Limb →
Pareses — all drugs for Pareses →

Sponsor

Otto Bock France SNC

Who can join

18 and older, any sex, with Lower Limb or Pareses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this multicentric study is to assess the impact of C-BRACE on mobility, endurance, confidence, participation, satisfaction, psychosocial adjustment and quality of life in community ambulators using a Stance Control Orthosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Otto Bock France SNC trials

Trials by the same sponsor.

NCT07214493 — Study on a Prosthetic Foot With Adjustable Heel Height · NA · recruiting
NCT06740006 — Retrospective Study on the WalkOn AFO in Children or Teenagers With Neurological Pathologies · completed
NCT05154175 — Effectiveness of Ottobock Helmet Therapy in Infants With Plagiocephaly, Brachycephaly or Combination of Both · completed
NCT04522349 — Compensatory Movements With Axon-Hook and Greifer in Transradial Amputees · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05332509 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Otto Bock France SNC
Last refreshed: 23 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05332509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing